ACTICOAT◊ FLEX Antimicrobial Barrier Dressings
Combines nanocrystalline silver (NCS) technology with a flexible low-adherent layer to conform to body contours, delivering a sustained antimicrobial action for up to 7 days*1-5
Your complete solution
See how S+N will be with you every step of the way in implementing!@#$%^&*() change.
See how S+N will be with you every step of the way in implementing change.
See how S+N will be with you every step of the way in implementing change.
-
See how S+N will be with you every step of the way in implementing change.
-
See how S+N will be with you every step of the way in implementing change.
See how S+N will be with you every step of the way in implementing change.
Titel
Titel
Titel
Titel
Titel
Product feature
Reference Materials
Responding to the needs of wound care clinicians and their patients, we’ve reinvented our flagship foam dressing technology to deliver a new, versatile solution designed to offer COMPLETE CARE.
Built to help defend patients against factors that contribute to pressure injuries*1-4 and helps minimise exudate leakage**5-7 with a next-generation, five-layer construction.
+ For pressure injury prevention:
Using ShearDEFENSE◊ Technology, ALLEVYN COMPLETE CARE Dressings absorb shear forces and reduce soft tissue strain to help minimise the risk of pressure injuries,*1,8,9 as part of a suitable prevention protocol1,8,9+ For exudate management:
Highly effective in absorbing and locking away low-high levels of exudate and bacteria, even under compression, including normal and viscous exudate.5,10-12 Shown to help manage bioburden**10,11,13 and minimise leakage5-7
Evidence and Case Studies
Medical Education
No results.
No results.
Disclaimer
*Depending on dressing selection. ACTICOAT FLEX 3 offers up to 3 days’ use. ACTICOAT FLEX 7 offers up to 7 days’ use.
**As demonstrated in vitro.
Citations
1. Smith+Nephew 2011. Internal report. SR/CE/036/ACB.
2. Smith+Nephew 2008. Internal report. DOF 0810016.
3. Smith+Nephew 2008. Internal report. DOF 0810017.
4. Smith+Nephew 2008. Internal report. DOF 0810012.
5. Smith+Nephew 2008. Internal report. DOF 0810013.
6. Smith+Nephew. A 17-Day wound healing study in full-thickness wounds in minipigs. Internal Statement.
7. Wright JB, et al. Am J Infect Control. 1998;26(6):572 - 577.
8. Wright JB, et al. Am J Infect Control. 1999;27(4):344 - 350.
9. Smith+Nephew 2017. Internal report. DS/16/363/R2.
10. Westaim Biomedical 2001. Internal report - 971030.
11. Smith+Nephew 2008. Internal report. DS/08/123/R1.
12. Cuttle L, et al. Burns. 2007;33(6):701 - 707.
13. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.001.v2.
14. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.002.v2.
15. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.003.v2.
16. Smith+Nephew 2020. Internal report. EO.AWM.PCS105.004.v2.
17. Gago M, et al. Wounds. 2008;20(10):273 - 278.
18. Demling RH, et al. Burns. 2002;28(3):264 - 266
19. Smith+Nephew 2008. Internal report. DOF 0810018.
20. Smith+Nephew 2008. Internal report. DOF 0810014.
21. Yin HQ, et al. J Burn Care Rehabil. 1999;20(3):195 - 200.
22. Wright JB, et al. Wounds. 1998;10(6):179 - 188.
23. Smith+Nephew 2008. Internal report. DS/08/062/R1.
24. Westaim Biomedical 2000. Internal report - 001213.
25. Westaim Biomedical 2001. Internal report - 010322.
26. Glik J, et al. Int Wound J. 2018;15(3):344 - 349.